Duke Cancer Review

Professional Register for the Duke Cancer Review
Dan Blazer Christine Eyler Linda Sutton Christopher Jones

Cure, Comfort, and Collaboration in Oncology Care

Duke Cancer Review provides a case-intensive and comprehensive summary of the most up-to-date research and clinical data presented at ASCO and other standard-setting professional scientific meetings. Each topic is presented by an esteemed Duke expert in the respective field, with an emphasis on the integration of interdisciplinary approaches to cancer treatment, community care perspectives, and strategies for translating advancements into cutting edge and thoughtful patient care. 

Duke Cancer Review will provide health care providers an overview of emerging data in the following malignancies: 

  • Gastrointestinal
  • Hematology
  • Genitourinary
  • Breast
  • Thoracic
  • Endocrine

Additional content will focus on: 

  • Stratification of incidental findings on CT 
  • Integration of palliative care and APP perspectives

For more information, contact Beth Tanner.

Register for the Duke Cancer Review

Agenda

Friday, July 19, 2024

  • 7:00 a.m.
    Registration and Breakfast 
  • 8:00 a.m. 
    Welcome/Moderator Morning Session, Daniel Blazer III, MD
  • 8:05 a.m.
    Key Note: The Times They Are A'Changin: Integration of Palliative Care in Oncology, Christopher Jones, MD, FAAHPM, MBA
  • 8:50 a.m.
    Advances in the Management of Gastrointestinal Cancers
    • Moderator - Nivetha Vishnuvardham, MBBS, MD (Johnston Oncology - Clayton) 
    • Medical Oncology - Aman Opneja, MBBS
    • Interventional Radiology - Charles Kim, MD 
    • Radiation Oncology Perspectives - Christine Eyler, MD, PhD
    • Surgical Perspectives - Allison Martin, MD, MPH
  • 10:20 a.m. Break 
  • 10:40 a.m.
    Advances in the Management of Hematologic Malignancies 
    • Moderator - David Mack, MD (Maria Parham)
    • Chronic Malignancies - Sanghee Hong, MD 
    • Lymphoma - Alexandra Stefanovic, MD
    • Radiation Oncology - Chris Kelsey, MD 
  • 12:10 p.m. Lunch
  • 1:10 p.m.
    Welcome Back/Moderator, Linda Sutton, MD
  • 1:15 p.m.
    Advances in the Management of Endocrine Cancers
    • Moderator - Carly Kelley, MD, MPH, ECNU
    • Medical Oncology - Jameel Muzaffar, MD
    • Surgical Oncology - Randall Scheri, MD
    • Nuclear Medicine - Colm Kelleher, MD 
  • 2:30 p.m. Break 
  • 2:45 p.m.
    Advances in the Management of Genitourinary Malignancies 
    • Moderator - Hui Chen, MD (Gibson) 
    • Medical Oncology - Hannah Dzimitrowicz McManus, MD
    • Radiation Oncology Perspectives - Matthew Boyer, MD, PhD
    • Radiology - Rajan Gupta, MD
  • 4:15 p.m.
    Clinical Debates in Pancreatic Cancer (Panel)
    • Manisha Palta, MD
    • Garth Herbert, MD, FACS
    • Kevin Shah, MD
    • Neeraj Agrawal, MD
  • 5:00 p.m.
    End-of-Day Wrap-Up

Saturday, July 20, 2024

  • 7:00 a.m.
    Registration and Breakfast 
  • 8:00 a.m. 
    Welcome/Moderator Morning Session, Christine Eyler, MD, PhD
  • 8:05 a.m.
    Advances in the Management of Breast Cancer
    • Moderator - Natalia Ferrari, MD (Maria Parham)
    • Medical Oncology - Madhu Chaudhry, MD
    • Radiation Oncology Perspectives - Diandra Ayala-Peacock, MD
    • Surgical Oncology - Akiko Chiba, MD, FACS
  • 9:35 a.m. 
    Palliative Care 
    • Journey to Palliative Care - Lisa Pickett, MD
    • Beyond Comfort: Unlocking the Full Potential of Palliative Care - Betsy Fricklas, PA-C, MMSc
  • 10:45 a.m. Break
  • 11:05 a.m.
    Advances in the Management of Thoracic Malignancies 
    • Moderator - Arati Patel, MD (CalvertHealth)
    • Medical Oncology - Laura Alder, MD 
    • Surgical Oncology - Hai Viet-Nguyen Salfity, MD, MPH
    • Radiation Oncology - Trey Mullikin, MD 
  • 12:35 p.m. End of Program
  • Breast Cancer
  • Endocrine Cancer
  • Gastrointestinal Cancer
  • Esophageal Cancer
  • Pancreatic Cancer
  • Genitourinary Cancer
  • Hematologic Malignancies and Cellular Therapy
  • Lung Cancer
  • Radiation Oncology and Imaging
    • Off
    gift purple logo
    duke health logo

    Read more about our patient care services, including treatments and locations of care, on DukeHealth.org

    DukeHealth
    Off

    The Umstead Hotel and Spa
    100 Woodland Pond Dr
    Cary, NC 27513
    United States

    illustration of a bladder surrounded by cancer cells
    Article

    Bladder Cancer Breakthrough Dramatically Extends Survival 

    People with advanced urothelial cancers — most of whom have bladder cancer — now have a new first-line treatment that will extend their survival for the first time in almost 40 years. The new treatment, approved by the Food and Drug Administration (FDA) on December 15, combines pembrolizumab, an immunotherapy agent, with enfortumab vedotin, an antibody drug conjugate. The FDA had previously approved the drug combination in April for people who are ineligible for cisplatin-containing chemotherapy, a much smaller group of people. Bladder cancer is the fifth most common cancer. Data from a phase three clinical trial, presented at the European Society of Medical Oncologists in October, showed that the experimental therapy nearly doubled the median survival to 31.5 months, compared to an average survival of just 16.5 months in the standard chemotherapy arm. Progression-free survival also doubled. Furthermore, a slowing of the progression rate after 18 months in almost 40% of the experimental arm suggests that some people may live much longer. Historically, only 5% of advanced bladder cancer patients survived five years.

    Duke Cancer Institute Blog
    Hannah Dzimitrowicz McManus
    Hannah Dzimitrowicz McManus

    Hannah McManus

    Assistant Professor of Medicine

    9/11 First Responder Kicks Off Prostate Cancer FUNdraiser

    man in backwards baseball cap gets his mustache shaved by woman holding razor to his face
    Retired New York City Police Department detective Bill Young gets his shave-down.
    Community Join Us for the Big Shave Off
    Andrew Armstrong Daniel George Michael Harrison

    by D'Ann George, program development coordinator, Duke Cancer Institute Development (Dec. 8, 2023)

    A group of 14 men standing together in front of six glass windows and a picture of a water tower
    THE "BEFORE" PHOTO Fifteen men volunteered to shear their whiskers for the cause, including five firemen from Morrisville, several Duke clinicians, a bartender from Fullsteam, and a retired police detective from New York City.
    Man in a backwards baseball cap and lit up reindeer antlers holds up a sparkly red dress
    FESTIVE Bob Young, in the holiday spirit, at Beer and Beards for Bros

    This year’s Beer and Beards for Bros, held for the first time since 2019, raised nearly $10,000 for research at the Duke Cancer Institute Center for Prostate and Urologic Cancers. By all appearances, the event, held at Fullsteam Brewery on Dec. 1, raised even more fun than funds.

    The 15 men who volunteered to shear their whiskers for the cause included five firemen from Morrisville, several Duke employees, a bartender from Fullsteam, dads with adorable children clinging to them, and a retired detective from the New York City Police Department, who was the first to part with his mustache.

    Even the auctioneer, Sam Poley, got into the action and bid off his own beard. Poley said he volunteered his time and talent in memory of his late father, who was treated for prostate cancer at Duke.

    Mohawks, Leopard Skins, and Pink Flamingos

    Auction winners directed a team of stylists from the Arrow “guaranteed shorter hair” barbershop on how they wanted the men shaved. Their crowning achievement came when one of the firemen incentivized the audience to bid higher by agreeing to “go full mohawk.”

    Before the night was over, all of the men shamelessly shed their street clothes to don frippery chosen by auction winners from a table of costumes.

    The bartender, who sported the thickest, blackest beard of them all, looked jarring in his blonde curly wig and white bedazzled frock.

    Travis Henry, MD, a Duke radiologist, dressed as a fluffy bear. Medical oncologist Mike Harrison, MD, wore a shirt emblazoned with giant pink flamingos and a red headband attached to a messy blonde wig.

    But the highest bid — almost $2,000 — went to Raj Gupta, MD, a DCI radiologist who sported a leopard coat and a white mink scarf. His dashing ensemble was chosen by his two young daughters, who placed the winning bid.

    Police Officer Wins “Most Hilarious” Contest

    The NYPD detective, Bob Young, struggled to squeeze into a strapless, red sparkly dress with a blue-and-white starred petticoat, which he topped off with reindeer antlers embellished with multi-colored Christmas lights.

    Young easily won the prize for “most hilarious.” But the sequins did not stop him from kicking off the event with a moving speech about why prostate cancer research and excellent clinical care mean so much to him.

    First Responders and Genitourinary Cancers

    "People usually get prostate cancer in their 60s, but the 9/11 responders were getting it in their 30s and 40s,” said Young.

    As president of the 50135 club, a benevolent association for retired police officers in Raleigh, Young said that "Beer and Beards for Bros" was the first charitable event that he has attended since the pandemic.

    Likewise, the five firemen who attended said that the shave-off was their first post-pandemic philanthropic event. Nick Young, president of the association, heard about the event from his fiancé, Sarah Omwenga, RN, an oncology nurse at Duke.

    Young said that testicular, thyroid, and throat cancer are prevalent among firefighters due to the chemical exposures they face on the job.

    “We’re coming back next year,” said the elder Young. “And we’re bringing friends. There are 120 retired policemen in my club. And 20 of them have cancer. I want the ones with prostate cancer to be seen at Duke.”

     

    From the Archives

    A woman uses a raiser to shave a man's face that's covered in shaving cream, and whose had iss wrapped in a white towel
    Daniel George, MD, visits Pedro Williams barbershop for a complimentary shave down before growing out his facial hair in November. (photo from 2015)
    Four men in white lab coats stand together
    FLASHBACK: In 2012, Michael Harrison, MD, Andrew Armstong, MD, MSc, Dan George, MD, and Judd Moul, MD, pose following their November grow out.
  • Genitourinary Cancer
  • Bladder Cancer
  • Center for Prostate and Urologic Cancers
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Giving
  • Fundraising Events
  • Give to Duke Cancer Institute
  • Center for Prostate and Urologic Cancers
    • Off
    gift purple logo
    duke health logo

    Read more about our patient care services, including treatments and locations of care, on DukeHealth.org

    DukeHealth
    Off

    Fullsteam Brewery
    726 Rigsbee Ave
    Durham, NC
    United States

    GU Public Symposium Includes Celebration of Berry's Retirement

    Duke Cancer Institute-labeled light blue binder
    Community REGISTER
    Daniel George Andrew Armstrong Michael Harrison Michael Abern
    Two men in suits pose in a conference hall
    Andrew Armstrong, MD, and William Berry, MD

    Update

    On September 29, community members, including cancer survivors and caregivers, learned about the latest clinical advances in the treatment of kidney, prostate, and bladder cancers during a live discussion among faculty/oncologists from the Duke Cancer Institute Center for Prostate & Urologic Cancers.

    Speakers included: William Berry, MD; Daniel George, MD; Michael Harrison, MD; Zach Reitman, MD, PhD; Ankeet Shah, MD; Michael Abern, MD; Andrew Armstrong, MD, MSc; Ryan Fecteau, MD, PhD; Christopher Hoimes, DO; Shahla Bari, MBBS; and Hannah McManus, MD.

    In a special session of the symposium William Berry, MD, was celebrated for his five-decade career in Medicine — beginning and ending at Duke — and interviewed by George. Berry, a DCI medical oncologist specializing in treating bladder, kidney, prostate, and testicular cancer, joined Duke on January 1, 1974, and will officially retire on Dec. 31, 2023. He earned his MD at Duke in 1973.

    Together, the 2023 Duke Cancer Institute Center for Prostate & Urologic Cancers Symposium (9/29/23) and Tackle Cancer Tailgate (9/30/23) raised $64,000 for prostate and urologic cancer research.

    Duke in the 1970s black and white slide of five young men in front of a stone building
    This slide was shown as part of a tribute to William Berry, MD, to illustrate Duke in the 1970s when he began his medical career.
  • Genitourinary Cancer
  • Bladder Cancer
  • Center for Prostate and Urologic Cancers
  • Kidney Cancer
  • Prostate Cancer
  • Giving
  • Fundraising Events
  • Center for Prostate and Urologic Cancers
  • Give to Duke Cancer Institute
    • On
    gift purple logo

    Support Prostate & Urologic Cancers Research

    Donate Now
    duke health logo

    Read more about our patient care services, including treatments and locations of care, on DukeHealth.org

    DukeHealth
    Off

    Trent Semans Center - Great Hall (on Duke campus)
    8 Searle Center Dr.
    Durham, NC
    United States

    WATCH VIDEO: Community Conversation on Ovarian Cancer

    Community

    UPDATE (SEPTEMBER 30, 2021): This event has concluded, but you can now watch a recording of the event above
    ovarian cancer awareness ribbonOn September 24, the Duke Cancer Institute Office of Health Equity presents the next event in its signature "Conversations with Our Community" series. The event — titled "Ovarian Cancer Signs & Symptoms, Early Detection, and Treatment Overview" — is targeted at community members.

    Ovarian cancer is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. There is no screening test for ovarian cancer, and only about 20% of ovarian cancers are found at an early stage. When ovarian cancer is found early, about 94% of patients live longer than five years after diagnosis.

    The hour-long discussion, held in conjunction with Gynecologic Cancer Awareness Month (September), will feature DCI medical oncologists Angeles Alvarez Secord, MD, MHSc, and Rafael Gonzalez, MD — both of whom specialize in the research and treatment of gynecological cancers — as well as DCI genetics counselor Maggie (Powell) Frazier, MS, CGC, and an ovarian cancer survivor.

    Kearston Ingraham, MPH, research program evaluator for OHE, will serve as moderator.
     

    Meet the Speakers

    Angeles Alvarez Secord, MD, MHSc,is a practicing medical oncologist specializing in female-specific cancers, a professor in the Duke Department of Obstetrics and Gynecology Obstetrics and Gynecology, Division of Gynecologic Oncology, and associate director of Clinical Research in the DCI Gynecologic Cancer Disease Group.

    Secord's clinical research interests include the utilization of anti-angiogenic therapies and/or molecularly-targeted therapies to improve patient outcomes, minimize unnecessary toxicity, and positively impact quality of life.

    She also specializes in robotic-assisted laparoscopic surgery for women with endometrial, ovarian, and cervical cancers as well as for benign gynecologic conditions.

    "I offer my patients access to variety of treatments ... I enjoy my work on female cancers, because it is one of the few sub-specialties to blend surgery and chemotherapy. It also gives me the chance to develop strong relationships with my patients, since I get to take care of my patients before and during their surgery, as well as continue to see them for the rest of their lifetime."

    Rafael Gonzalez, MD, is a clinical fellow in the Division of Gynecologic Oncology whose research focuses on surgical outcomes.

    Maggie (Powell) Frazier, MS, CGC, is a certified genetics counselor with Duke Clinical Cancer Genetics at DCI. As a certified genetic counselor, she helps patients better understand their risk for developing cancer and provides guidance on how to turn this information into action in order to reduce cancer occurrence or increase early detection in patient and their family members.

    "Whether you have already been diagnosed with cancer, have a diagnosis of a hereditary cancer syndrome, or have a family history of cancer, I can navigate you through the role of genetic testing, risk analysis, and connecting you with the experienced specialists you may need.

    Learn More About the Duke Cancer Institute Office of Health Equity

    ACCESS the DCI Office of Health Equity website

    Vision: To excel as the leader in reducing cancer disparities through authentic community engagement and partnerships, the delivery of seamless cancer care, and the provision of outstanding and innovative research and resources to achieve optimal health in a changing and diverse environment.

    Mission: To reduce cancer disparities and promote health equity within Duke Cancer Institute's catchment area through strategic initiatives that integrate the following core areas:

    • Community Outreach & Engagement
    • Community-Facing Patient Navigation Services
    • Health Disparities Education
    • Clinical Trials Education & Workplace Diversity

    Email us or call 919.684.0409 with any questions about our "Conversations with Our Community" events, patient navigation services and any other questions you might have.

  • Cancer Genetics
  • Conversations with Our Community
  • Health Equity
  • Genitourinary Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Gynecologic Cancer
  • Endocrine Neoplasia
    • Off
    gift purple logo
    duke health logo

    Read more about our patient care services, including treatments and locations of care, on DukeHealth.org

    DukeHealth
    Off

    NC
    United States

    WATCH: OHE, Nuestras Voces Cervical Cancer Community Forum

    Community

     

    On January 25, the Duke Cancer Institute Office of Health Equity and community partner Nuestras Voces convened a virtual community forum — "Cervical Cancer: Early Detection Saves Lives" — as part of their "Conversations with the Community" series.
    A panel of experts, including DCI gynecologic oncologists Angeles Alvarez Secord, MD, MHS, and Rafael Gonzalez, MD, together with patient navigator Nadia Aguilera-Funez (DCI Office of Health Equity), discussed cervical cancer screening and diagnosis & the role of patient navigation as a way to help reduce cancer disparities among the medically underserved.

    Attendees also heard from Teri L. Larkins, PhD (CDC Division of Cancer Prevention and Control) about the Centers for Disease Control's National Breast and Cervical Cancer Early Detection Program.

    When cervical cancer is found early, it is highly treatable and associated with long-term survival and good quality of life. Unfortunately, the U.S. has lower up-to-date HPV vaccination rates than other high-income countries.

  • Cancer Genetics
  • Conversations with Our Community
  • Health Equity
  • Liver Cancer
  • Genitourinary Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Gynecologic Cancer
  • Cervical Cancer
  • Gynecologic Cancer
  • Community Outreach, Engagement, and Equity
    • Off
    gift purple logo
    duke health logo

    Read more about our patient care services, including treatments and locations of care, on DukeHealth.org

    DukeHealth
    Off

    NC
    United States